Generate a tailored SOP for Dr. John Scott. Improve your application with a focused, well-structured draft.
Dr. John D. Scott is the Edwin G. Krebs-Speights Professor of Cell Signaling at the University of Washington, where he specializes in pharmacology and cancer biology. His research focuses on drug discovery, precision medicine, and the molecular basis of disease, particularly through the study of intracellular signaling pathways. He has made significant contributions to understanding the role of A-kinase Anchoring Proteins (AKAPs) in regulating protein kinases and phosphatases within defined cellular locations. His research employs a combination of molecular, genetic, and structural approaches to elucidate the spatial regulation of physiological processes and how dysregulation can lead to various disease states, including cardiovascular diseases, diabetes, and cancers. Dr. Scott has received numerous accolades for his work, including the 2024 ASPET Julius Axelrod Award and the Oppenheimer Award from the Endocrine Society. He is recognized as a Fellow of the Royal Society (London) and the Royal Society of Edinburgh, and he serves on various scientific advisory boards across the USA, UK, Europe, Australia, and Asia.
University of Washington • Seattle, WA
Leading research and teaching in the field of pharmacology, focusing on drug discovery and intracellular signaling.
Standard Graduate School requirements for University of Washington apply to most departments listed unless specified otherwise by the program.